Angiotensin-converting enzyme gene 2350 G/A polymorphism is associated with left ventricular hypertrophy but not essential hypertension

Hypertension Research

Volumn 30, Issue 1, 2007, Pages 31-37

  Pan, Min ^a   Zhu, Jian Hua ^a   Liu, Zhi Hua ^b   Jiang, Wen Ping ^b   Cui, Zhi Chu ^a   Yu, Xiao Hong ^a   Li, Hong Mei ^a   Yang, Xiang Jun ^b  

^a NANTONG UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

Angiotensin converting enzyme; Essential hypertension; Genetic polymorphism; Left ventricular hypertrophy

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; GENOMIC DNA;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; ENZYME BLOOD LEVEL; ESSENTIAL HYPERTENSION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE SIZE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ADENINE; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GUANINE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; LOGISTIC MODELS; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RISK;

EID: 33847065384     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.30.31     Document Type: Article

References (33)

1. Ward R: Familial aggregation and genetic epidemiology of blood pressure, in Laragh JH, Brenner BM (eds): Hypertension: Pathophysiology, Diagnosis, and Management. New York, Raven Press, 1990, pp 81-100.
2. Takai S, Jin D, Sakaguchi M, Miyazaki M: Significant target organs for hypertension and cardiac hypertrophy by angiotensin-converting enzyme inhibitors. Hypertens Res 2004; 27: 213-219.
3. Watt GC, Harrap SB, Foy CJ, et al: Abnormalities of glucocorticoid metabolism and the renin-angiotensin system: a four-corners approach to the identification of genetic determinants of blood pressure. J Hypertens 1992; 10: 473-482.
4. Kawamoto R, Kohara K, Tabara Y, Miki T: An interaction between systolic blood pressure and angiotensin-converting enzyme gene polymorphism on carotid atherosclerosis. Hypertens Res 2002; 25: 875-880.
5. Danser AHJ, Schalekamp MADH, Bax WA, et al: Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 1995; 92: 1387-1388.
6. Zee R, Lou YK, Griffiths LR, et al: Association of a polymorphism of angiotensin converting enzyme gene with essential hypertension. Biochem Biophys Res Commun 1992; 184: 9-15.
7. Tamaki S, Nakamura Y, Tsujita Y, et al: Polymorphism of the angiotensin converting enzyme gene and blood pressure in a Japanese general population (the Shigaraki Study). Hypertens Res 2002; 25: 843-848.
8. Tanaka C, Kamide K, Takiuchi S, et al: An alternative fast and convenient genotyping method for the screening of angiotensin converting enzyme gene polymorphisms. Hypertens Res 2003; 26: 301-306.
9. Levy D, DeStefano AL, Larson MG, et al: Evidence for a gene influencing blood pressure on chromosome 17: genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the Framingham Heart Study. Hypertension 2000; 36: 477-483.
10. Zhu X, Bouzekri N, Southam L, et al: Linkage and association analysis of angiotensin I-converting enzyme (ACE)-gene polymorphisms with ACE concentration and blood pressure. Am J Hum Genet 2001; 68: 1139-1148.
11. Sahn DJ, De Maria A, Kisslo J, Weyman A: The Committee on M-Mode Standardization of the American Society: recommendations regarding quantitation in M-mode echocardiography. Circulation 1978; 58: 1071-1083.
12. Devereux RB, Reichek N: Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 1977; 55: 613-618.
13. Levy D: Clinical significance of left ventricular hypertrophy: insights from the Framingham Study. J Cardiovasc Pharmacol 1991; 17: 1-6.
14. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH: Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114: 345-352.
15. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
16. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F: An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-1346.
17. O'Donnell CJ, Lindpaitner K, Larson MG, et al: Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation 1998; 97: 1766-1772.
18. Fornage M, Amos CI, Kardia S, et al: Variation in the region of the angiotensin-converting enzyme gene influences interindividual differences in blood pressure levels in young white males. Circulation 1998; 97: 1773-1779.
19. Higaki J, Baba S, Katsuya T, et al: Deletion allele of angiotensin-converting enzyme gene increases risk of essential hypertension in Japanese men. Circulation 2000; 101: 2060.
20. Gesang L, Liu G, Cen W, et al: Angiotensin-converting enzyme gene polymorphism and its association with essential hypertension in a Tibetan population. Hypertens Res 2002; 25: 481-485.
21. Staessen JA, Wang JG, Ginocchio G, et al: The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular renal risk. J Hypertens 1997; 15: 1579-1592.
22. Czarnecka D, Kawecka-Jaszcz K, Stolarz K, et al: Genetic factors in hypertension. Angiotensin-converting enzyme polymorphism. Kardiol Pol 2004; 61: 1-10.
23. Saeed Mahmood M, Saboohi K, Osman Ali S, Bokhari AM, Frossard PM: Association of the angiotensin-converting enzyme (ACE) gene G2350A dimorphism with essential hypertension. J Hum Hypertens 2003; 17: 719-723.
24. Asai T, Kushiro T, Fujita H, Kanmatsuse K: Different effects on inhibition of cardiac hypertrophy in spontaneously hypertensive rats by monotherapy and combination therapy of adrenergic receptor antagonists and/or the angiotensin II type 1 receptor blocker under comparable blood pressure reduction. Hypertens Res 2005; 28: 79-87.
25. Yasumoto K, Takata M, Ueno H, Tomoda F, Inoue H: Relation of circulating blood volume to left ventricular geometry in essential hypertension. Hypertens Res 2002; 25: 703-710.
26. Fu Y, Katsuya T, Matsuo A, et al: Relationship of bradykinin B2 receptor gene polymorphism with essential hypertension and left ventricular hypertrophy. Hypertens Res 2004; 27: 933-938.
27. Iwashima Y, Horio T, Kuroda S, Takishita S, Kawano Y: Influence of plasma aldosterone on left ventricular geometry and diastolic function in treated essential hypertension. Hypertens Res 2002; 25: 49-56.
28. Schunkert H, Hense H, Holmer S, et al: Association between a deletion polymorphism of the angiotensin converting enzyme gene and left ventricular hypertrophy. N Engl J Med 1994; 330: 1634-1638.
29. Inomata H, Watanabe T, Iizuka Y, et al: Identification of quantitative trait loci for cardiac hypertrophy in two different strains of the spontaneously hypertensive rat. Hypertens Res 2005; 28: 273-281.
30. Saeed M, Saleheen D, Siddiqui S, Khan A, Butt ZA, Frossard PM: Association of angiotensin converting enzyme gene polymorphisms with left ventricular hypertrophy. Hypertens Res 2005; 28: 345-349.
31. Saeed M, Mekan SF, Rabbani MA, Arain FM, Arif M, Shaharyar S: Angiotensin converting enzyme (ACE) gene polymorphisms and lupus disease severity: a promising link. Ann Rheum Dis 2005; 64; 164-165.
32. Kehoe PG, Katzov H, Feuk L, et al: Haplotypes extending across ACE are associated with Alzheimer's disease. Hum Mol Genet 2003; 12: 8859-8867.
33. Duan J, Wainwright MS, Comeron JM, et al: Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet 2003; 12: 205-216.